CClinicalTrials.gg
RecruitingNCT07618416Updated Jun 1, 2026

Machine Learning Model Based on Baroreflex Sensitivity for Predicting Post-Induction Hypotension in Elderly Patients

An observational study in Post Induction Hypotension, sponsored by Peking Union Medical College Hospital. Recruiting at 1 site in China. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by Peking Union Medical College Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
65 Years and older
Sex
All
01

Study summary

The purpose of this study is to develop a high-performance machine learning model combining dynamic baroreflex sensitivity (BRS) metrics and multi-dimensional static clinical features to predict the risk of post-induction hypotension (PIH) in elderly patients undergoing elective non-cardiac surgery under general anesthesia.

Read the detailed description

Aging significantly alters cardiovascular autonomic function, characterized by elevated sympathetic and decreased parasympathetic tone, rendering elderly patients highly vulnerable to post-induction hypotension (PIH). While existing machine learning models heavily rely on static data (e.g., baseline blood pressure, demographics, medication history), they lack real-time dynamic regulatory inputs, limiting their predictive performance in individualized care.

This single-center, prospective cohort study aims to bridge this gap by introducing preoperative BRS parameters-calculated via the continuous non-invasive arterial pressure (CNAP) method-into machine learning frameworks. A total of 500 patients aged over 65 years scheduled for elective non-cardiac surgery will be enrolled. Preoperative data, including autonomic indices, frailty assessments, and static clinical factors, will be mapped alongside intraoperative events and 30-day postoperative complications. Multiple machine learning algorithms (Logistic Regression, Random Forest, GBDT, XGBoost, LightGBM, and LSTM) will be leveraged and optimized using cross-validation to construct a robust clinical decision-support pipeline.

02

Conditions studied

  • Post Induction Hypotension

Keywords

  • post-induction hypotension
  • elderly patient
  • baroreflex sensitivity
  • machine learning
03

In context

Lead sponsor

Peking Union Medical College Hospital is the lead sponsor of 1,115 studies on the registry; 463 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients scheduled for elective operations

Inclusion criteria

  • Aged over 65 years;
  • Scheduled for elective non-cardiac surgery;
  • American Society of Anesthesiologists (ASA) physical status classification I-III;
  • Planned for general anesthesia with endotracheal intubation;
  • Patient and legal guardians are capable of understanding the study protocol and willing to provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  • Severe peripheral vascular diseases;
  • Secondary hypertension;
  • Presence of physical tremors (e.g., Parkinson's disease) preventing stable recording;
  • Inability to accurately measure upper limb blood pressure;
  • Pre-existing cardiac arrhythmias (e.g., atrial fibrillation) that render BRS;
  • Psychiatric disorders or cognitive impairments hindering basic cooperation.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Elderly Surgical Patients

    Patients aged over 65 years who are undergoing elective non-cardiac surgery under general anesthesia with endotracheal intubation. All patients will receive continuous non-invasive hemodynamic monitoring prior to anesthesia induction to calculate baseline BRS parameters.

06

What researchers measure

Primary outcomes

  1. Incidence of Post-Induction Hypotension (PIH)

    Defined as a systolic blood pressure (SBP) \<90 mmHg , a mean arterial pressure (MAP) \<65 mmHg, or a decrease in MAP exceeding 30% from baseline measurements.

    Time frame: From immediately after anesthesia induction up to 20 minutes post-induction or before surgical incision.

Secondary outcomes

  1. 1. Early Intraoperative Hypotension Rate

    Defined as a systolic blood pressure (SBP) \<90 mmHg , a mean arterial pressure (MAP) \<65 mmHg, or a decrease in MAP exceeding 30% from baseline measurements.

    Time frame: From surgical incision to the end of the operation.

  2. Postoperative Complication

    Time frame: Up to 30 days post-surgery

07

Study locations

1 of 1 sites recruiting
  • Peking Union Medical College Hospital
    Beijing, China 100730, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07618416
Lead sponsor
Peking Union Medical College Hospital
Responsible party
Huang YuGuang (Professor, Peking Union Medical College Hospital) — Principal investigator
First posted
Jun 1, 2026
Start date
Jun 1, 2026 (estimated)
Primary completion
Sep 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Jun 1, 2026

Study contacts

Quexuan Cui, Dr.
Contact
Cuiqx_garfield@126.com
+8613520921711

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion